Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment

Annals of Behavioral Medicine

Volumn 42, Issue 1, 2011, Pages 120-126

  Gonzalez, Jeffrey S ^a,b   Psaros, Christina ^b,c   Batchelder, Abigail ^a   Applebaum, Allison ^d   Newville, Howard ^a   Safren, Steven A ^b,c  

^a YESHIVA UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adherence; Assessment; Depression; HAART; HIV; Methadone maintenance

Indexed keywords

METHADONE;

ADDICTION; ARTICLE; DEPRESSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SELF REPORT; STATISTICS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 79960584325     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-011-9268-y     Document Type: Article

References (25)

1. NF Crum RH Riffenburgh S Wegner, et al. 2006 Comparisons of causes of death and mortality rates among HIV infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras J Acq Immun Def Synd. 41 2 194 200 10.1097/01.qai.0000179459.31562.16
2. Glass TR, De Geest S, Hirschel B, et al. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther. 2008; (13): 77-85.
3. MR DiMatteo HS Lepper TW Croghan 2000 Depression is a risk factor for noncompliance with medical treatment - Meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med. 160 14 2101 2107 10904452 10.1001/archinte.160.14.2101 1:STN:280:DC%2BD3czptVKgug%3D%3D (Pubitemid 30482715)
4. EG Bing A Burnam D Longshore, et al. 2001 Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States Arch Gen Psychiat. 58 8 721 728 11483137 10.1001/archpsyc.58.8.721 1:STN:280:DC%2BD3MvptFGitw%3D%3D (Pubitemid 32717795)
5. JS Tucker MA Burnam CD Sherbourne F Kuong AL Gifford 2003 Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection Am J Med. 114 7 573 580 12753881 10.1016/S0002-9343(03)00093-7 (Pubitemid 36577260)
6. GJ Wagner 2002 Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries AIDS Patient Care ST. 16 12 599 608 10.1089/108729102761882134 (Pubitemid 36008059)
7. T Gibbie M Hay CW Hutchison A Mijch 2007 Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS Sexual Health. 4 4 227 232 18082064 10.1071/SH06062 (Pubitemid 350158745)
8. JS Gonzalez FJ Penedo MH Antoni, et al. 2004 Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS Health Psychol. 23 4 413 418 15264978 10.1037/0278-6133.23.4.413 (Pubitemid 38880174)
9. C O'Cleirigh G Ironson A Weiss PT Costa 2007 Conscientiousness predicts disease progression (CD4 Number and Viral Load) in people living with HIV Health Psychol. 26 4 473 480 17605567 10.1037/0278-6133.26.4.473 (Pubitemid 47454583)
10. A Ammassari A Antinori MS Aloisi, et al. 2004 Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons Psychosomatics. 45 5 394 402 15345784 10.1176/appi.psy.45.5.394 (Pubitemid 39166911)
11. JH Arnsten X Li Y Mizuno, et al. 2007 Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users J Acq Immun Def Synd. 46 S64 S71 10.1097/QAI. 0b013e31815767d6 (Pubitemid 350293782)
12. SK Avants A Margolin LA Warburton KA Hawkins 2001 Predictors of nonadherence to HIV-related medication regimes during methadone stabilization Am J Addiction. 10 69 78 10.1080/105504901750160501 1:STN:280: DC%2BD3M7mslyguw%3D%3D (Pubitemid 32201734)
13. JH Arnsten PA Demas RW Grant, et al. 2002 Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV+ drug users J Gen Intern Med. 17 5 377 381 12047736 (Pubitemid 34626108)
14. K Berg P Demas A Howard E Schoenbaum M Gourevitch J Arnsten 2004 Gender differences in factors associated with adherence to antiretroviral therapy J Gen Intern Med. 19 11 1111 1117 15566440 10.1111/j.1525-1497.2004.30445.x (Pubitemid 39552581)
15. Beck AT. Cognitive therapy of depression. 1979; The Guilford Press: New York, NY.
16. Matt GE, Vázquez C, Campbell KW. Mood-congruent recall of affectively toned stimuli: A meta-analytic review. Clin Psychol Rev. 1992; 12(2): 227-255.
17. RA Hansen SB Dusetzina L Song BN Gaynes W Tu MD Murray 2009 Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients J Am Pharm Assoc. 49 6 760 768 10.1331/JAPhA.2009.08184
18. DV Sheehan Y Lecrubier KH Sheehan, et al. 1998 The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiat. 59 Suppl 20 22 33 (Pubitemid 29001829)
19. SA Montgomery M Asberg 1979 A new depression scale designed to be sensitive to change Br J Psychiat. 13 4 382 389 10.1192/bjp.134.4.382 (Pubitemid 9136500)
20. Guy W. Clinical Global Impression. ECDEU Assessment Manual for Psychopharmacology. U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH. 1976; 218-222.
21. AT Beck WY Rial K Rickels 1974 Short form of depression inventory: Cross-validation Psychol Rep. 34 3 1184 1186 4424377 1:STN:280: DyaE2M%2Fjtlegtg%3D%3D
22. WM Reynolds JW Gould 1981 A psychometric investigation of the standard and short form Beck Depression Inventory J Consult Clin Psych. 49 2 306 307 10.1037/0022-006X.49.2.306 1:STN:280:DyaL3M7mvVyqtQ%3D%3D (Pubitemid 13249469)
23. AT McLellan L Luborsky GE Woody CP O'Brien 1980 An improved diagnostic evaluation instrument for substance abuse patients: The Addiction Severity Index J Nerv Ment Dis. 168 1 26 33 7351540 10.1097/00005053-198001000-00006 1:STN:280:DyaL3c%2Fps1Srsw%3D%3D (Pubitemid 10187569)
24. The World Health Organization. The Management of Substance Abuse Page. http://www.who.int/substance-abuse/research-tools/addictionseverity/en/index. html. Accessibility verified December 4, 2010.
25. J Cohen 1992 A power primer Psychol Bull. 112 1 155 159 19565683 10.1037/0033-2909.112.1.155 1:STN:280:DC%2BD1MvlsV2mug%3D%3D